Yarrow Bioscience, Inc. (YARW)

17.31 -0.62 (-3.46%) USD  |  NASDAQ  |  Nov 03, 13:31
More

Yarrow Bioscience Debt to Equity Ratio : 0.00 for June 30, 2026

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.0006
March 31, 2025 0.0014
December 31, 2024 0.0019
September 30, 2024 0.0019
June 30, 2024 0.0019
March 31, 2024 0.0022
December 31, 2023 0.0024
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.0006
March 31, 2022 0.0021
December 31, 2021 0.0072
September 30, 2021 0.0179
Date Value
June 30, 2021 0.4623
March 31, 2021 0.3736
December 31, 2020 0.9277
September 30, 2020 0.711
June 30, 2020 0.4959
March 31, 2020 0.4969
December 31, 2019 1.961
September 30, 2019 0.0099
June 30, 2019 0.0099
March 31, 2019 0.0059
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017
March 31, 2017
December 31, 2016 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 0.0003
Cue Biopharma, Inc. 3.813
Faeth Therapeutics, Inc. 0.0033
Indaptus Therapeutics, Inc. 0.00
Pyxis Oncology, Inc. 1.559

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 23.60M
Total Liabilities (Quarterly) 1.542M
Shareholders Equity (Quarterly) 22.06M
Current Ratio 15.26
Net Debt Paydown Yield 0.06%